MECHANISMS OF GH RESISTANCE IN SEPSIS
脓毒症中 GH 抵抗的机制
基本信息
- 批准号:6386676
- 负责人:
- 金额:$ 10.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-05-01 至 2002-04-30
- 项目状态:已结题
- 来源:
- 关键词:JAK kinase bacterial disease binding proteins biological signal transduction blood toxicology cytokine receptors disease /disorder model enzyme activity gastrocnemius muscle gene expression hormone inhibitor hormone receptor hormone regulation /control mechanism insulinlike growth factor interleukin 1 laboratory rat liver cells messenger RNA northern blottings phosphorylation protein metabolism receptor expression somatotropin transcription factor western blottings
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract) The development of
growth hormone (GH) resistance following injury and sepsis results in the
catabolism of body protein. GH normally stimulates the release of
insulin-like growth factor 1 (IGF-1) which upregulates protein synthesis in
many tissues. The chronic abdominal sepsis model used in the P.I.'s
laboratory mimics many features of GH resistance observed in injured and
septic patients. Thus, the applicant is in an excellent position to
delineate the mechanisms of this cell signaling defect. Infusion of a
specific interleukin-1 receptor antagonist (IL-1ra) significantly
ameliorates protein catabolism and GH resistance in septic rats. This
suggests that IL-1 is an important mediator of GH resistance in sepsis. The
overall goal of this project will be to determine the mechanisms by which
IL-1 mediates the development of GH resistance and protein catabolism in
chronic abdominal sepsis. GH insensitivity may be caused by alterations in
GH bioavailability, quantitative or qualitative defects in the GH receptor
(GHR), postreceptor defects in GHR signal transduction, or by altered
expression of GH responsive genes. The GHR is present in many tissues,
however, the highest concentrations are in liver. GH binding protein (GHBP)
binds circulating GH and modulates its bioavailability. GH forms a
dimerized complex with GHR activating a phosphorylation cascade.
Postreceptor signaling involves tyrosine phosphorylation of GHR by Janus
kinase 2 (JAK2), JAK2 autophosphorylation, activation of transcription
factor(s), and increased expression of "target" genes including: IGF-1 and
Spi-2 (serine protease inhibitor). The liver is the major source of
circulating IGF-1 (endocrine), however, most tissues including muscle
contain and transcribe the IGF genes (paracrine). The applicant plans to
examine GHBP/GHR and IGF-1 expression in both liver and muscle to
investigate whether endocrine and paracrine regulation regulatory mechanisms
are important in sepsis. The specific aims of the project are: (1) to
examine the effects of sepsis and IL-1ra on GHBP expression; (2) to examine
the effects of sepsis and IL-1 antagonism on GHR expression and GH binding
activity; (3) to examine the effects of sepsis and IL-1ra on GH induced
tyrosine phosphorylation of hepatic proteins and JAK 2 kinase activation;
(4) and to examine the effects of sepsis and IL-1ra on IGF-1 and Spi-2 mRNA
expression. These studies will reveal the molecular mechanisms by which
IL-1ra ameliorates the development of GH resistance in sepsis.
描述:(改编自申请人的摘要)的发展
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes.
Interleukin-1 抑制 CWSV-1 肝细胞中生长激素诱导的胰岛素样生长因子-I。
- DOI:10.1152/ajpgi.00424.2004
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Shumate,MargaretL;Yumet,Gladys;Ahmed,TamerA;Cooney,RobertN
- 通讯作者:Cooney,RobertN
Chronic infusion of interleukin 1 induces hyperlactatemia and altered regulation of lactate metabolism in skeletal muscle.
- DOI:10.1177/0148607199023004213
- 发表时间:1999-07
- 期刊:
- 影响因子:0
- 作者:T. Vary;P. O'Neill;R. Cooney;G. Maish;M. Shumate
- 通讯作者:T. Vary;P. O'Neill;R. Cooney;G. Maish;M. Shumate
Roux-en-Y gastric bypass alters small intestine glutamine transport in the obese Zucker rat.
Roux-en-Y 胃绕道术改变了肥胖 Zucker 大鼠的小肠谷氨酰胺转运。
- DOI:10.1152/ajpgi.00104.2009
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Wolff,BrynnS;Meirelles,Katia;Meng,Qinghe;Pan,Ming;Cooney,RobertN
- 通讯作者:Cooney,RobertN
TNF binding protein prevents hyperlactatemia and inactivation of PDH complex in skeletal muscle during sepsis.
- DOI:10.1006/jsre.1998.5324
- 发表时间:1998-11
- 期刊:
- 影响因子:0
- 作者:T. Vary;S. Hazen;G. Maish;R. Cooney
- 通讯作者:T. Vary;S. Hazen;G. Maish;R. Cooney
Revisional bariatric surgery: who, what, where, and when?
- DOI:10.1016/j.soard.2010.04.005
- 发表时间:2010-11-01
- 期刊:
- 影响因子:3.1
- 作者:Radtka, John F., III;Puleo, Frances J.;Cooney, Robert N.
- 通讯作者:Cooney, Robert N.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT N. COONEY其他文献
ROBERT N. COONEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT N. COONEY', 18)}}的其他基金
DOES RYGB ALTER CIRCULATING GUT-DERIVED PEPTIDES IN MORBIDLY OBESE PATIENTS
RYGB 是否会改变病态肥胖患者的循环肠道衍生肽
- 批准号:
8365478 - 财政年份:2011
- 资助金额:
$ 10.51万 - 项目类别:
DOES RYGB ALTER CIRCULATING GUT-DERIVED PEPTIDES IN MORBIDLY OBESE PATIENTS
RYGB 是否会改变病态肥胖患者的循环肠道衍生肽
- 批准号:
8170719 - 财政年份:2010
- 资助金额:
$ 10.51万 - 项目类别:
Mechanisms of Growth Hormone Resistance in Sepsis
脓毒症生长激素抵抗机制
- 批准号:
6874500 - 财政年份:1997
- 资助金额:
$ 10.51万 - 项目类别:
Mechanisms of Growth Hormone Resistance in Sepsis
脓毒症生长激素抵抗机制
- 批准号:
7664261 - 财政年份:1997
- 资助金额:
$ 10.51万 - 项目类别:
Mechanisms of Growth Hormone Resistance in Sepsis
脓毒症生长激素抵抗机制
- 批准号:
7039046 - 财政年份:1997
- 资助金额:
$ 10.51万 - 项目类别:
Mechanisms of Growth Hormone Resistance in Sepsis
脓毒症生长激素抵抗机制
- 批准号:
6733557 - 财政年份:1997
- 资助金额:
$ 10.51万 - 项目类别:
相似海外基金
Development of Host induced Gene Editing (Hi-GE): a novel platform for bacterial disease control
宿主诱导基因编辑(Hi-GE)的开发:细菌性疾病控制的新平台
- 批准号:
10004717 - 财政年份:2021
- 资助金额:
$ 10.51万 - 项目类别:
Collaborative R&D
Elucidation of the pathogenic mechanism of black spot bacterial disease using a comprehensive screening method
利用综合筛查方法阐明黑斑细菌性疾病的致病机制
- 批准号:
19K06045 - 财政年份:2019
- 资助金额:
$ 10.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The relationship between malarial anaemia, neutrophil function and susceptibility to invasive bacterial disease.
疟疾贫血、中性粒细胞功能与侵袭性细菌性疾病易感性之间的关系。
- 批准号:
MR/P000959/2 - 财政年份:2017
- 资助金额:
$ 10.51万 - 项目类别:
Research Grant
Redefining the role of autophagy in bacterial disease
重新定义自噬在细菌性疾病中的作用
- 批准号:
10519116 - 财政年份:2016
- 资助金额:
$ 10.51万 - 项目类别:
Redefining the role of autophagy in bacterial disease
重新定义自噬在细菌性疾病中的作用
- 批准号:
10053295 - 财政年份:2016
- 资助金额:
$ 10.51万 - 项目类别:
Redefining the role of autophagy in bacterial disease
重新定义自噬在细菌性疾病中的作用
- 批准号:
10764559 - 财政年份:2016
- 资助金额:
$ 10.51万 - 项目类别:
The relationship between malarial anaemia, neutrophil function and susceptibility to invasive bacterial disease.
疟疾贫血、中性粒细胞功能与侵袭性细菌性疾病易感性之间的关系。
- 批准号:
MR/P000959/1 - 财政年份:2016
- 资助金额:
$ 10.51万 - 项目类别:
Research Grant
Redefining the role of autophagy in bacterial disease
重新定义自噬在细菌性疾病中的作用
- 批准号:
10384537 - 财政年份:2016
- 资助金额:
$ 10.51万 - 项目类别:
The treatment of bacterial disease of plants by bacteriophage coated nanoparticles
噬菌体包被纳米颗粒治疗植物细菌性疾病
- 批准号:
BB/K501979/1 - 财政年份:2013
- 资助金额:
$ 10.51万 - 项目类别:
Training Grant
Identification of disease resistance loci against bacterial disease (Streptococcus iniae)in rainbow trout(Oncorhynchus mykiss)
虹鳟鱼(Oncorhynchus mykiss)细菌性病害(海豚链球菌)抗病位点的鉴定
- 批准号:
22780188 - 财政年份:2010
- 资助金额:
$ 10.51万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




